HomeFPSUF • OTCMKTS
add
Capha Pharmaceuticals Inc
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.33K | -34.82% |
Net income | -19.55K | 0.34% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -10.30K | 34.83% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 653.00 | -2.68% |
Total assets | 1.80K | 3.26% |
Total liabilities | 572.32K | 14.12% |
Total equity | -570.51K | — |
Shares outstanding | 64.43M | — |
Price to book | -0.00 | — |
Return on assets | -1,269.62% | — |
Return on capital | 247.81% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -19.55K | 0.34% |
Cash from operations | -20.27K | 28.25% |
Cash from investing | — | — |
Cash from financing | 19.50K | -27.78% |
Net change in cash | -769.00 | 38.53% |
Free cash flow | -7.18K | 61.29% |
About
Headquarters
